BioNexus Gene Lab Corp Common stock (BGLC) had the best year between 2020 and 2022 by a US stock in 2021, returning 11,112,943.5%.

ASSET	YEAR	% RETURN
BioNexus Gene Lab Corp Common stock (BGLC)	2021	11,112,943.48%
Connexa Sports Technologies (YYAI)	2020	7,199,900%
MDxHealth SA ADR (MDXH)	2021	865,354.55%
Integra Resources (ITRG)	2020	653,233.33%
Next Technology (NXTT)	2022	451,006.25%
INVO Fertility (IVF)	2020	250,733.33%
Heart Test Laboratories Inc Common Stock (HSCS)	2022	246,958.82%
Guardforce AI (GFAI)	2021	207,592.31%
SS Innovations International Inc Common Stock (SSII)	2022	126,150%
Bone Biologics (BBLG)	2021	67,484%
CIMG (IMG)	2020	59,315.14%
Castellum (CTM)	2022	14,900%
Applied Digital (APLD)	2021	11,073.33%
COSCIENS Biopharma (CSCI)	2020	9,006.78%
Ascent Solar Technologies, Inc Common Stock (ASTI)	2020	7,900%
Bit Digital (BTBT)	2020	5,377.5%
American Battery Technology Company Common Stock (ABAT)	2020	4,275%
Graf Industrial Corp Warrants (each warrant exercisable for one-half of one share of common stock each at an exercise price of $1150 per share) (GRAF.WT)	2020	2,944.83%
Novavax (NVAX)	2020	2,694.74%
HIVE Blockchain Technologies (HIVE)	2020	2,506.9%
Foremost Lithium Resource & Technology Ltd Common stock (FMST)	2022	2,400%
Diversified Energy (DEC)	2022	2,343.66%
Kaival Brands Innovations (KAVL)	2020	2,288.89%
Blink Charging (BLNK)	2020	2,186.1%
Vivid Seats (SEAT)	2021	2,080.32%